Balentine LLC’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9,408
| Closed | -$1.27M | – | 216 |
|
|
2024
Q1 | $1.27M | Buy |
9,408
+2,662
| +39% | +$352K | 0.04% | 153 |
|
|
2023
Q4 | $909K | Buy |
6,746
+4,310
| +177% | +$560K | 0.03% | 185 |
|
|
2023
Q3 | $330K | Sell |
2,436
-128
| -5% | -$17.5K | 0.01% | 347 |
|
|
2023
Q2 | $367K | Buy |
2,564
+132
| +5% | +$19.4K | 0.01% | 340 |
|
|
2023
Q1 | $338K | Buy |
2,432
+13
| +0.5% | +$1.75K | 0.01% | 378 |
|
|
2022
Q4 | $328K | Sell |
2,419
-446
| -16% | -$55.9K | 0.01% | 427 |
|
|
2022
Q3 | $314K | Sell |
2,865
-1,368
| -32% | -$174K | 0.01% | 382 |
|
|
2022
Q2 | $559K | Sell |
4,233
-2,299
| -35% | -$302K | 0.02% | 287 |
|
|
2022
Q1 | $867K | Buy |
6,532
+2,899
| +80% | +$348K | 0.03% | 195 |
|
|
2021
Q4 | $423K | Buy |
3,633
+676
| +23% | +$79.5K | 0.01% | 193 |
|
|
2021
Q3 | $355K | Sell |
2,957
-112
| -4% | -$13K | 0.01% | 159 |
|
|
2021
Q2 | $368K | Buy |
+3,069
| New | +$337K | 0.01% | 100 |
|
|
2020
Q3 | – | Sell |
-1,026
| Closed | -$108K | – | 206 |
|
|
2020
Q2 | $108K | Buy |
+1,026
| New | +$106K | 0.01% | 142 |
|
|
2019
Q4 | – | Sell |
-666
| Closed | -$59K | – | 611 |
|
|
2019
Q3 | $59K | Hold |
666
| – | – | ﹤0.01% | 121 |
|
|
2019
Q2 | $55K | Buy |
666
+85
| +15% | +$6.67K | ﹤0.01% | 101 |
|
|
2019
Q1 | $47K | Buy |
581
+257
| +79% | +$20.3K | ﹤0.01% | 125 |
|
|
2018
Q4 | $25K | Hold |
324
| – | – | ﹤0.01% | 168 |
|
|
2018
Q3 | $26K | Buy |
324
+84
| +35% | +$6.35K | ﹤0.01% | 114 |
|
|
2018
Q2 | $17K | Buy |
+240
| New | +$17.3K | ﹤0.01% | 72 |
|
|
2018
Q1 | – | Sell |
-744
| Closed | -$52K | – | 99 |
|
|
2017
Q4 | $52K | Sell |
744
-18
| -2% | -$1.21K | ﹤0.01% | 270 |
|
|
2017
Q3 | $52K | Buy |
+762
| New | +$48.1K | ﹤0.01% | 256 |
|
Other funds holding AZN
